Literature DB >> 35727504

Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome.

Christina Christersson1, Tomasz Baron2, Frank Flachskampf2, Lars Lindhagen3, Bertil Lindahl2,3, Agneta Siegbahn4.   

Abstract

A proportion of patients with the acute coronary syndrome (ACS) will suffer progressive remodeling of the left ventricular (LV). The aim was to screen for important biomarkers from a large-scale protein profiling in 420 ACS patients and define biomarkers associated with reduced LV function early and 1 year after the ACS. Transferrin receptor protein 1 and NT-proBNP were associated with LV function early and after 1 year, whereas osteopontin and soluble ST2 were associated with LV function in the early phase and, tissue-type plasminogen activator after 1 year. Fatty-acid-binding protein and galectin 3 were related to worse GLS but not to LVEF 1 year after the ACS. Proteins involved in remodeling and iron transport in cardiomyocytes were related to worse LV function after ACS. Biomarkers for energy metabolism and fibrosis were exclusively related to worse LV function by GLS. Studies on the functions of these proteins might add knowledge to the biological processes involved in heart failure in long term after ACS.
© 2022. The Author(s).

Entities:  

Keywords:  Acute coronary syndrome; Heart failure; Left ventricular function; Soluble biomarkers

Year:  2022        PMID: 35727504     DOI: 10.1007/s12265-022-10285-2

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  50 in total

1.  Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.

Authors:  Justin A Ezekowitz; Padma Kaul; Jeffery A Bakal; Paul W Armstrong; Robert C Welsh; Finlay A McAlister
Journal:  J Am Coll Cardiol       Date:  2009-01-06       Impact factor: 24.094

Review 2.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

3.  Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008.

Authors:  Liyew Desta; Tomas Jernberg; Ida Löfman; Claes Hofman-Bang; Inger Hagerman; Jonas Spaak; Hans Persson
Journal:  JACC Heart Fail       Date:  2015-03       Impact factor: 12.035

4.  Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study.

Authors:  S D Solomon; R J Glynn; S Greaves; U Ajani; J L Rouleau; F Menapace; J M Arnold; C Hennekens; M A Pfeffer
Journal:  Ann Intern Med       Date:  2001-03-20       Impact factor: 25.391

Review 5.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

6.  Prognostic value of exercise testing, coronary angiography and left ventriculography 6--8 weeks after myocardial infarction.

Authors:  P J De Feyter; M J van Eenige; D H Dighton; F C Visser; J de Jong; J P Roos
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

Review 7.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

Review 8.  Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction.

Authors:  Peter C Westman; Michael J Lipinski; Dror Luger; Ron Waksman; Robert O Bonow; Edwin Wu; Stephen E Epstein
Journal:  J Am Coll Cardiol       Date:  2016-05-03       Impact factor: 24.094

Review 9.  Inflammatory mediators and the failing heart: a translational approach.

Authors:  Abhinav Diwan; Tony Tran; Arunima Misra; Douglas L Mann
Journal:  Curr Mol Med       Date:  2003-03       Impact factor: 2.222

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.